全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

Deep Learning for Personalized Pharmacotherapy in Pregnant Women with Psychiatric Disorders

DOI: 10.4236/oalib.1113512, PP. 1-17

Subject Areas: Psychiatry & Psychology

Keywords: Deep Learning, Personalized Pharmacotherapy, Pregnancy, Psychiatric Disorders, Electronic Health Records, Drug Efficacy

Full-Text   Cite this paper   Add to My Lib

Abstract

Managing psychiatric disorders, including depression, anxiety, and bipolar disorder, during pregnancy presents significant clinical challenges due to uncertainties surrounding medication safety and efficacy for both the mother and fetus. This study introduces a novel deep learning (DL)-based decision-support framework aimed at personalizing pharmacotherapy for pregnant patients diagnosed with psychiatric conditions. By leveraging electronic health records (EHRs), pharmacogenomic data, and advanced machine learning techniques, we developed a predictive neural network model capable of recommending precise drug classes and dosages tailored to individual patient profiles. Our methodology consisted of clearly defined sequential phases: problem definition, data collection, preprocessing, feature engineering, exploratory data analysis (EDA), model development, genetic data integration, validation, and deployment into clinical practice. Exploratory analysis revealed critical insights, identifying significant predictors of medication efficacy and side effects through visualizations including pair plots, correlation heatmaps, violin plots, and interactive scatter plots. The developed neural network model, optimized using rigorous hyperparameter tuning, exhibited high accuracy and robust predictive power, as evidenced by outstanding ROC-AUC and precision-recall performance metrics. Integration of pharmacogenomic data further improved predictive accuracy, demonstrating the model’s ability to capture complex genetic interactions influencing drug response variability. Rigorous validation through retrospective cohort studies confirmed the clinical applicability and reliability of our system. Ultimately, our decision-support tool provides clinicians with evidence-based, individualized medication strategies that effectively balance therapeutic outcomes and safety concerns during pregnancy. The application of this DL-driven personalized pharmacotherapy framework holds significant potential for enhancing clinical decision-making, improving maternal mental health, and minimizing risks to fetal development.

 Cite this paper

Filippis, R. D. and Foysal, A. A. (2025). Deep Learning for Personalized Pharmacotherapy in Pregnant Women with Psychiatric Disorders. Open Access Library Journal, 12, e3512. doi: http://dx.doi.org/10.4236/oalib.1113512.

References

[1]  Cantwell, R. (2021) Mental Disorder in Pregnancy and the Early Postpartum. Anaesthesia, 76, 76-83. https://doi.org/10.1111/anae.15424
[2]  Rusner, M., Berg, M. and Begley, C. (2016) Bipolar Disorder in Pregnancy and Childbirth: A Systematic Review of Outcomes. BMC Pregnancy and Childbirth, 16, Article No. 331. https://doi.org/10.1186/s12884-016-1127-1
[3]  Meltzer-Brody, S., Howard, L.M., Bergink, V., Vigod, S., Jones, I., Munk-Olsen, T., et al. (2018) Postpartum Psychiatric Disorders. Nature Reviews Disease Primers, 4, Article No. 18022. https://doi.org/10.1038/nrdp.2018.22
[4]  Paschetta, E., Berrisford, G., Coccia, F., Whitmore, J., Wood, A.G., Pretlove, S., et al. (2014) Perinatal Psychiatric Disorders: An Overview. American Journal of Obstetrics and Gynecology, 210, 501-509.e6. https://doi.org/10.1016/j.ajog.2013.10.009
[5]  Oyebode, F., Rastogi, A., Berrisford, G. and Coccia, F. (2012) Psychotropics in Pregnancy: Safety and Other Considerations. Pharmacology & Therapeutics, 135, 71-77. https://doi.org/10.1016/j.pharmthera.2012.03.008
[6]  Erdeljić, V., Francetić, I., Makar-Aušperger, K., Likić, R. and Radačić-Aumiler, M. (2010) Clinical Pharmacology Consultation: A Better Answer to Safety Issues of Drug Therapy during Pregnancy? European Journal of Clinical Pharmacology, 66, 1037-1046. https://doi.org/10.1007/s00228-010-0867-5
[7]  Eberhard-Gran, M., Eskild, A. and Opjordsmoen, S. (2005) Treating Mood Disorders during Pregnancy. Drug Safety, 28, 695-706. https://doi.org/10.2165/00002018-200528080-00004
[8]  Redfern, W.S., Wakefield, I.D., Prior, H., Pollard, C.E., Ham-mond, T.G. and Valentin, J. (2002) Safety Pharmacology—A Progressive Approach. Fundamental & Clinical Pharmacology, 16, 161-173. https://doi.org/10.1046/j.1472-8206.2002.00098.x
[9]  Schaefer, C., Peters, P.W.J. and Miller, R.K. (2014) Drugs during Pregnancy and Lactation: Treatment Options and Risk Assessment. Academic Press.
[10]  Nguyen, T., Seiler, N., Brown, E. and O’Donoghue, B. (2020) The Effect of Clinical Practice Guidelines on Prescribing Practice in Mental Health: A Systematic Review. Psychiatry Research, 284, Article ID: 112671. https://doi.org/10.1016/j.psychres.2019.112671
[11]  Galbally, M., Frayne, J., Watson, S.J. and Snellen, M. (2019) Psy-chopharmacological Prescribing Practices in Pregnancy for Women with Severe Mental Illness: A Multicentre Study. Euro-pean Neuropsychopharmacology, 29, 57-65. https://doi.org/10.1016/j.euroneuro.2018.11.1103
[12]  Yonkers, K.A., Wisner, K.L., Stewart, D.E., Oberlander, T.F., Dell, D.L., Stotland, N., et al. (2009) The Management of Depression during Pregnancy: A Report from the American Psychiatric Association and the American College of Obstetricians and Gynecol-ogists. General Hospital Psychiatry, 31, 403-413. https://doi.org/10.1016/j.genhosppsych.2009.04.003
[13]  McAllister-Williams, R.H., Baldwin, D.S., Cantwell, R., Easter, A., Gilvarry, E., Glover, V., et al. (2017) British Association for Psychopharmacology Consensus Guidance on the Use of Psy-chotropic Medication Preconception, in Pregnancy and Postpartum 2017. Journal of Psychopharmacology, 31, 519-552. https://doi.org/10.1177/0269881117699361
[14]  Ortega, V.E. and Meyers, D.A. (2014) Pharmacogenetics: Implications of Race and Ethnicity on Defining Genetic Profiles for Personalized Medicine. Journal of Allergy and Clinical Immunology, 133, 16-26. https://doi.org/10.1016/j.jaci.2013.10.040
[15]  Ette, E.I. and Williams, P.J. (2004) Population Pharmacoki-netics I: Background, Concepts, and Models. Annals of Pharmacotherapy, 38, 1702-1706. https://doi.org/10.1345/aph.1d374
[16]  Diekstra, M., Fritsch, A., Kanefendt, F., Swen, J., Moes, D., Sörgel, F., et al. (2017) Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients with Sunitinib-Treated Cancer. CPT: Pharmacometrics & Systems Pharmacology, 6, 604-613. https://doi.org/10.1002/psp4.12210
[17]  Kantae, V., Krekels, E.H.J., Esdonk, M.J.V., Lindenburg, P., Harms, A.C., Knibbe, C.A.J., et al. (2016) Integration of Pharmacometabolomics with Pharmacokinetics and Pharmacodynamics: Towards Person-alized Drug Therapy. Metabolomics, 13, Article No. 9. https://doi.org/10.1007/s11306-016-1143-1
[18]  Weathers, S.S. and Gilbert, M.R. (2017) Toward Personalized Targeted Therapeutics: An Overview. Neurotherapeutics, 14, 256-264. https://doi.org/10.1007/s13311-016-0496-5
[19]  Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., et al. (2024) Advancing Precision Medicine: A Review of Innovative in Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics, 16, Article 332. https://doi.org/10.3390/pharmaceutics16030332
[20]  Espinosa, C., Becker, M., Marić, I., Wong, R.J., Shaw, G.M., Gaudil-liere, B., et al. (2021) Data-Driven Modeling of Pregnancy-Related Complications. Trends in Molecular Medicine, 27, 762-776. https://doi.org/10.1016/j.molmed.2021.01.007
[21]  Taherdoost, H. and Ghofrani, A. (2024) AI and the Evolu-tion of Personalized Medicine in Pharmacogenomics. Intelligent Pharmacy, 2, 643-650.
[22]  Primorac, D., Bach-Rojecky, L., Vađunec, D., Juginović, A., žunić, K., Matišić, V., et al. (2020) Pharmacogenomics at the Center of Precision Medicine: Chal-lenges and Perspective in an Era of Big Data. Pharmacogenomics, 21, 141-156. https://doi.org/10.2217/pgs-2019-0134
[23]  Xiao, C., Choi, E. and Sun, J. (2018) Opportunities and Challenges in De-veloping Deep Learning Models Using Electronic Health Records Data: A Systematic Review. Journal of the American Medical Informatics Association, 25, 1419-1428. https://doi.org/10.1093/jamia/ocy068
[24]  Ahmed, Z., Mohamed, K., Zeeshan, S. and Dong, X. (2020) Artificial Intelligence with Multi-Functional Machine Learning Platform Development for Better Healthcare and Precision Medicine. Database, 2020, baaa010. https://doi.org/10.1093/database/baaa010
[25]  Jena, O.P., Bhushan, B. and Kose, U. (2022) Machine Learning and Deep Learning in Medical Data Analytics and Healthcare Ap-plications. CRC Press.
[26]  Zafar, I., Anwar, S., kanwal, F., Yousaf, W., Un Nisa, F., Kausar, T., et al. (2023) Reviewing Methods of Deep Learning for Intelligent Healthcare Systems in Genomics and Biomedicine. Biomedical Signal Processing and Control, 86, Article ID: 105263. https://doi.org/10.1016/j.bspc.2023.105263
[27]  Bennett, R., Hemmati, M., Ramesh, R. and Razzaghi, T. (2024) Artificial Intelligence and Machine Learning in Precision Health: An Overview of Meth-ods, Challenges, and Future Directions. In: Kotsireas, I.S., Nagurney, A., Pardalos, P.M., Pickl, S.W. and Vogiatzis, C., Eds., Dynamics of Disasters, Springer, 15-53. https://doi.org/10.1007/978-3-031-74006-0_2
[28]  Sharmila, K.S. and Chandra, K.R. (2024) Predicting Adverse Interactions: A Comprehensive Review of Ai-Driven Drug-Drug Interaction Models for En-hanced Patient Safety. 2024 International Conference on IoT Based Control Networks and Intelligent Systems (ICICNIS), Bengaluru, 17-18 December 2024, 1098-1102. https://doi.org/10.1109/icicnis64247.2024.10823221
[29]  Iqbal, A.B., Shah, I.A., Injila, Assad, A., Ahmed, M. and Shah, S.Z. (2024) A Review of Deep Learning Algorithms for Modeling Drug Interactions. Multimedia Systems, 30, Article No. 124. https://doi.org/10.1007/s00530-024-01325-9
[30]  Ibrahim, A.A., Mohammed, T.A. and Dara, O.N. (2024) Predicting Big Data Drug Interactions and Associated Side Effects by Using Artifi-cial Neural Networks (ANN) over Traditional Graph Convolutional Networks (GCNs). https://doi.org/10.21203/rs.3.rs-3997856/v1
[31]  Mak, K., Wong, Y. and Pichika, M.R. (2024) Artificial Intelligence in Drug Discovery and Development. In: Hock, F.J. and Pugsley, M.K., Eds., Drug Discovery and Evaluation: Safety and Phar-macokinetic Assays, Springer, 1461-1498. https://doi.org/10.1007/978-3-031-35529-5_92
[32]  Shastry, B.S. (2005) Pharmacogenetics and the Concept of Individualized Medicine. The Pharmacogenomics Journal, 6, 16-21. https://doi.org/10.1038/sj.tpj.6500338
[33]  Ilan, Y. (2022) Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases. Journal of Personalized Medicine, 12, Article 1303. https://doi.org/10.3390/jpm12081303
[34]  Pittman, J., Huang, E., Dressman, H., Horng, C., Cheng, S.H., Tsou, M., et al. (2004) Integrated Modeling of Clinical and Gene Expression Information for Personalized Prediction of Disease Out-comes. Proceedings of the National Academy of Sciences of the United States of America, 101, 8431-8436. https://doi.org/10.1073/pnas.0401736101
[35]  Chen, Y., Hsiao, T., Lin, C. and Fann, Y.C. (2025) Unlocking Precision Medicine: Clinical Applications of Integrating Health Records, Genetics, and Immunology through Artificial Intelligence. Journal of Biomedical Science, 32, Article No. 16. https://doi.org/10.1186/s12929-024-01110-w
[36]  Boehm, K.M., Khosravi, P., Vanguri, R., Gao, J. and Shah, S.P. (2021) Harnessing Multimodal Data Integration to Advance Precision On-cology. Nature Reviews Cancer, 22, 114-126. https://doi.org/10.1038/s41568-021-00408-3
[37]  Castaneda, C., Nalley, K., Mannion, C., Bhattacharyya, P., Blake, P., Pecora, A., et al. (2015) Clinical Decision Support Systems for Improving Diag-nostic Accuracy and Achieving Precision Medicine. Journal of Clinical Bioinformatics, 5, Article No. 4. https://doi.org/10.1186/s13336-015-0019-3
[38]  Samson Enitan, S., Ngozi Adejumo, E., Osaigbovoh Imaralu, J., Ademola Adelakun, A., Anike Ladipo, O. and Bosede Enitan, C. (2023) Personalized Medicine Approach to Osteoporosis Management in Women: Integrating Genetics, Pharmacogenomics, and Precision Treatments. Clinical Research Communications, 6, Arti-cle 18. https://doi.org/10.53388/crc2023018
[39]  von Dadelszen, P., Magee, L.A., Payne, B.A., Dunsmuir, D.T., Drebit, S., Dumont, G.A., et al. (2015) Moving Beyond Silos: How Do We Provide Distributed Personalized Medicine to Pregnant Women Everywhere at Scale? Insights from Pre-Empt. International Journal of Gynecology & Obstetrics, 131, S10-S15. https://doi.org/10.1016/j.ijgo.2015.02.008
[40]  Delanerolle, G., Yang, X., Shetty, S., Raymont, V., Shetty, A., Phiri, P., et al. (2021) Artificial Intelligence: A Rapid Case for Advancement in the Personalization of Gynaecology/Obstetric and Mental Health Care. Women’s Health, 17. https://doi.org/10.1177/17455065211018111
[41]  Ghanem, M., Ghaith, A.K. and Bydon, M. (2024) Artificial Intelligence and Personalized Medicine: Transforming Patient Care. In: Bydon, M., Ed., The New Era of Precision Medicine, Elsevier, 131-142. https://doi.org/10.1016/b978-0-443-13963-5.00012-1
[42]  Schork, N.J. (2019) Artificial Intelligence and Personalized Medicine. In: Von Hoff, D. and Han, H., Eds., Precision Medicine in Cancer Therapy, Springer, 265-283. https://doi.org/10.1007/978-3-030-16391-4_11
[43]  Sahu, M., Gupta, R., Ambasta, R.K. and Kumar, P. (2022) Artificial Intelligence and Machine Learning in Precision Medicine: A Paradigm Shift in Big Data Analysis. Progress in Molecular Biology and Translational Science, 190, 57-100. https://doi.org/10.1016/bs.pmbts.2022.03.002
[44]  Costa, B. and Vale, N. (2024) Advances in Psychotropic Treatment for Pregnant Women: Efficacy, Adverse Outcomes, and Therapeutic Monitoring. Journal of Clinical Medicine, 13, Article 4398. https://doi.org/10.3390/jcm13154398
[45]  Edinoff, A.N., Sathivadivel, N., McNeil, S.E., Ly, A.I., Kweon, J., Kelkar, N., et al. (2022) Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complica-tions, and Postnatal Risks. Neurology International, 14, 62-74. https://doi.org/10.3390/neurolint14010005
[46]  Porter, I., Gonçalves-Bradley, D., Ricci-Cabello, I., Gibbons, C., Gangannagaripalli, J., Fitzpatrick, R., et al. (2016) Framework and Guidance for Implementing Patient-Reported Outcomes in Clinical Practice: Evidence, Challenges and Opportunities. Journal of Comparative Effectiveness Research, 5, 507-519. https://doi.org/10.2217/cer-2015-0014
[47]  Kent, D.M., Steyerberg, E. and van Klaveren, D. (2018) Personalized Evidence Based Medicine: Predictive Approaches to Heterogeneous Treatment Effects. BMJ, 363, k4245. https://doi.org/10.1136/bmj.k4245
[48]  Cohen, A.M., Stavri, P.Z. and Hersh, W.R. (2004) A Categorization and Analysis of the Criticisms of Evidence-Based Medicine. International Journal of Medical Informatics, 73, 35-43. https://doi.org/10.1016/j.ijmedinf.2003.11.002
[49]  Weiner, S.J., Schwartz, A., Weaver, F., Goldberg, J., Yudkowsky, R., Sharma, G., et al. (2010) Contextual Errors and Failures in Individualizing Patient Care. Annals of Internal Medicine, 153, 69-75. https://doi.org/10.7326/0003-4819-153-2-201007200-00002
[50]  Chekroud, A.M., Bondar, J., Delgadillo, J., Doherty, G., Wasil, A., Fokkema, M., Cohen, Z., et al. (2021) The Promise of Machine Learning in Predicting Treatment Outcomes in Psychiatry. World Psychiatry, 20, 154-170. https://doi.org/10.1002/wps.20882
[51]  de Pablo, S., et al. (2021) Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice. Schizophrenia Bulletin, 47, 284-297. https://doi.org/10.1093/schbul/sbaa120
[52]  Garriga, R., Mas, J., et al. (2022) Machine Learning Model to Predict Mental Health Crises from Electronic Health Records. Nature Medicine, 28, 1240-1248. https://doi.org/10.1038/s41591-022-01811-5
[53]  Shickel, B., Tighe, P.J., Bihorac, A. and Rashidi, P. (2018) Deep EHR: A Survey of Recent Advances in Deep Learning Techniques for Electronic Health Record (EHR) Analysis. IEEE Journal of Biomedical and Health Informatics, 22, 1589-1604. https://doi.org/10.1109/jbhi.2017.2767063
[54]  Tong, L., Shi, W., Isgut, M., Zhong, Y., Lais, P., Gloster, L., et al. (2024) Integrating Multi-Omics Data with EHR for Precision Medicine Using Advanced Artificial Intelligence. IEEE Reviews in Biomedical Engineering, 17, 80-97. https://doi.org/10.1109/rbme.2023.3324264
[55]  Ross, N.E., Webster, T.G., et al. (2022) Reproductive Decision-Making Capacity in Women with Psychiatric Illness: A Systematic Review. Journal of the Academy of Consultation-Liaison Psychiatry, 63, 61-70. https://doi.org/10.1016/j.jaclp.2021.08.007
[56]  Hippman, C.L. (2020) Promoting Perinatal Mental Health: Personalizing Treatment Decision Making Strategies through Decision-Making Support and Pharmacogenetics. Ph.D. Thesis, University of British Columbia.
[57]  Wisner, K.L., Zarin, D.A., Holmboe, E.S., Appelbaum, P.S., Gelenberg, A.J., Leonard, H.L., et al. (2000) Risk-Benefit Decision Making for Treatment of Depression during Pregnancy. American Journal of Psychi-atry, 157, 1933-1940. https://doi.org/10.1176/appi.ajp.157.12.1933
[58]  Carlin, A. and Alfirevic, Z. (2008) Physiologi-cal Changes of Pregnancy and Monitoring. Best Practice & Research Clinical Obstetrics & Gynaecology, 22, 801-823. https://doi.org/10.1016/j.bpobgyn.2008.06.005
[59]  Gaiser, R. (2009) Physiologic Changes of Pregnancy. Chestnut’s Obstetric Anesthesia: Principles and Practice, 4, 15-36. https://doi.org/10.1016/b978-0-323-05541-3.00002-8
[60]  Tobore, I., Li, J., Yuhang, L., Al-Handarish, Y., Kandwal, A., Nie, Z., et al. (2019) Deep Learning Intervention for Health Care Challenges: Some Biomedical Domain Considerations. JMIR mHealth and uHealth, 7, e11966. https://doi.org/10.2196/11966
[61]  Morid, M.A., Sheng, O.R.L. and Dunbar, J. (2023) Time Series Prediction Using Deep Learning Methods in Healthcare. ACM Transactions on Management Information Sys-tems, 14, 1-29. https://doi.org/10.1145/3531326
[62]  Wang, Y., Liu, L. and Wang, C. (2023) Trends in Using Deep Learning Algorithms in Biomedical Prediction Systems. Frontiers in Neuroscience, 17, Article 1256351. https://doi.org/10.3389/fnins.2023.1256351
[63]  Howard, L.M. and Khalifeh, H. (2020) Perinatal Mental Health: A Re-view of Progress and Challenges. World Psychiatry, 19, 313-327. https://doi.org/10.1002/wps.20769
[64]  Brockington, I., Butterworth, R. and Glangeaud-Freudenthal, N. (2016) An International Position Paper on Mother-Infant (Perinatal) Mental Health, with Guidelines for Clinical Practice. Archives of Women’s Mental Health, 20, 113-120. https://doi.org/10.1007/s00737-016-0684-7
[65]  Epstein, R., Moore, K. and Bobo, W. (2014) Treatment of Bipolar Dis-orders during Pregnancy: Maternal and Fetal Safety and Challenges. Drug, Healthcare and Patient Safety, 7, 7-29. https://doi.org/10.2147/dhps.s50556
[66]  Fisher, J. and Stocky, A. (2003) Maternal Perinatal Mental Health and Multi-ple Births: Implications for Practice. Twin Research, 6, 506-513. https://doi.org/10.1375/136905203322686509

Full-Text


Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705